Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03163303 · ClinicalTrials.gov registry record · Phase 4
Smoking Tobacco and Drinking Study
A Phase 4 study of Smoking and Heavy Episodic Drinking, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 179
- Enrollment target
- 1
- Study location
NCT03163303: Completed Phase 4 study of Smoking and Heavy Episodic Drinking, sponsored by University of California, San Francisco.
NCT03163303 is a Phase 4 study of Smoking and Heavy Episodic Drinking that has completed, run by University of California, San Francisco. The registered enrollment target is 179 participants, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03163303, a Phase 4 study of Smoking and Heavy Episodic Drinking, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 179 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will test the efficacy of a 3-month intervention on Facebook targeting tobacco use and heavy episodic drinking against a 3-month Facebook intervention targeting tobacco use. Both groups will be offered a nicotine patch starter kit. The primary outcome is verified 7-day point prevalence abstinence from smoking at 3, 6, and 12 months.
Primary Outcome
Point prevalent abstinence was defined as biochemically-verified reports of no smoking in the 7 days prior to the 3 month assessment. Participants reporting no smoking in the past 7 days will be coded as abstinent from cigarettes. Participants with a salivary cotinine level \<11 ng/ml, indicating nonsmoking were considered confirmed nonsmokers
Conditions Studied
Interventions
- DRUG nicotine patch
- BEHAVIORAL Tobacco Status Project Intervention
- BEHAVIORAL Tobacco Status Project + Alcohol Intervention
Study Locations (1)
California
- University of California San Francisco Department of Psychiatry - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
What the finished NCT03163303 record still lists
NCT03163303 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 454-participant average among 123 other Smoking trials with a reported enrollment target (61% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 3 interventions - of which nicotine patch is the first listed.
NCT03163303 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03163303 about?
NCT03163303 is a clinical study titled "Smoking Tobacco and Drinking Study". This trial will test the efficacy of a 3-month intervention on Facebook targeting tobacco use and heavy episodic drinking against a 3-month Facebook intervention targeting tobacco use. Both groups will be offered a nicotine patch starter kit. The primary outcome is verified 7-day point prevalence ab...
What is the current status of trial NCT03163303?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 179 participants. The study started on 2017-12-18. Estimated completion is 2019-06-30.
What conditions does trial NCT03163303 study?
This clinical trial studies the following conditions: Smoking, Heavy Episodic Drinking.
What interventions are being tested in trial NCT03163303?
The interventions under investigation include: nicotine patch (DRUG), Tobacco Status Project Intervention (BEHAVIORAL), Tobacco Status Project + Alcohol Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03163303?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03163303 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03163303's enrollment target sits among peer trials
179 60th of 123 higher than 64 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
Identifying Treatments to Motivate Smokers to Quit
COMPLETED · Phase 4
-
Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease
COMPLETED · Phase 4
-
Long-term Varenicline Treatment for Smoking Cessation
COMPLETED · Phase 4
-
Bupropion SR Plus Counseling for Smoking Cessation
COMPLETED · Phase 4
-
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI